Glutamate Receptor Ionotropic NMDA 2B Market
1 Study Coverage
1.1 Glutamate Receptor Ionotropic NMDA 2B Product Introduction
1.2 Global Glutamate Receptor Ionotropic NMDA 2B Outlook 2017 VS 2022 VS 2028
1.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in US$ Million for the Year 2017-2028
1.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume for the Year 2017-2028
1.3 United States Glutamate Receptor Ionotropic NMDA 2B Outlook 2017 VS 2022 VS 2028
1.3.1 United States Glutamate Receptor Ionotropic NMDA 2B Sales in US$ Million for the Year 2017-2028
1.3.2 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Volume for the Year 2017-2028
1.4 Glutamate Receptor Ionotropic NMDA 2B Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Glutamate Receptor Ionotropic NMDA 2B in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Glutamate Receptor Ionotropic NMDA 2B Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Glutamate Receptor Ionotropic NMDA 2B Market Dynamics
1.5.1 Glutamate Receptor Ionotropic NMDA 2B Industry Trends
1.5.2 Glutamate Receptor Ionotropic NMDA 2B Market Drivers
1.5.3 Glutamate Receptor Ionotropic NMDA 2B Market Challenges
1.5.4 Glutamate Receptor Ionotropic NMDA 2B Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Glutamate Receptor Ionotropic NMDA 2B Market Segment by Type
2.1.1 JNJ-0808
2.1.2 Neu-2000
2.1.3 NP-10679
2.1.4 NP-11948
2.1.5 Radiprodil
2.1.6 Others
2.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
2.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
2.3.1 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Glutamate Receptor Ionotropic NMDA 2B Market Segment by Application
3.1.1 Acute Ischemic Stroke
3.1.2 Autism
3.1.3 Brain Ischemia
3.1.4 Burns
3.1.5 Others
3.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
3.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
3.3.1 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Glutamate Receptor Ionotropic NMDA 2B Competitor Landscape by Company
4.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Company
4.1.1 Top Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Ranked by Revenue (2021)
4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturer (2017-2022)
4.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturer (2017-2022)
4.1.4 Global Glutamate Receptor Ionotropic NMDA 2B Price by Manufacturer (2017-2022)
4.2 Global Glutamate Receptor Ionotropic NMDA 2B Concentration Ratio (CR)
4.2.1 Glutamate Receptor Ionotropic NMDA 2B Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Glutamate Receptor Ionotropic NMDA 2B in 2021
4.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base Distribution, Product Type
4.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Type
4.3.3 Date of International Manufacturers Enter into Glutamate Receptor Ionotropic NMDA 2B Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Glutamate Receptor Ionotropic NMDA 2B Market Size by Company
4.5.1 Top Glutamate Receptor Ionotropic NMDA 2B Players in United States, Ranked by Revenue (2021)
4.5.2 United States Glutamate Receptor Ionotropic NMDA 2B Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Glutamate Receptor Ionotropic NMDA 2B Sales by Players (2020, 2021 & 2022)
5 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region
5.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size in Volume by Region (2017-2028)
5.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region: 2017-2022
5.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Forecast by Region (2023-2028)
5.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Size in Value by Region (2017-2028)
5.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region: 2017-2022
5.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
6.1.2 North America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
6.3.2 Europe Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
6.4.2 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 BioCrea GmbH
7.1.1 BioCrea GmbH Corporation Information
7.1.2 BioCrea GmbH Description and Business Overview
7.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.1.5 BioCrea GmbH Recent Development
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporation Information
7.2.2 Bristol-Myers Squibb Company Description and Business Overview
7.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.2.5 Bristol-Myers Squibb Company Recent Development
7.3 Cerecor Inc.
7.3.1 Cerecor Inc. Corporation Information
7.3.2 Cerecor Inc. Description and Business Overview
7.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.3.5 Cerecor Inc. Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporation Information
7.4.2 Johnson & Johnson Description and Business Overview
7.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.4.5 Johnson & Johnson Recent Development
7.5 Luc Therapeutics, Inc.
7.5.1 Luc Therapeutics, Inc. Corporation Information
7.5.2 Luc Therapeutics, Inc. Description and Business Overview
7.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.5.5 Luc Therapeutics, Inc. Recent Development
7.6 NeurOp, Inc
7.6.1 NeurOp, Inc Corporation Information
7.6.2 NeurOp, Inc Description and Business Overview
7.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.6.5 NeurOp, Inc Recent Development
7.7 Novartis AG
7.7.1 Novartis AG Corporation Information
7.7.2 Novartis AG Description and Business Overview
7.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.7.5 Novartis AG Recent Development
7.8 UCB S.A.
7.8.1 UCB S.A. Corporation Information
7.8.2 UCB S.A. Description and Business Overview
7.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
7.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Products Offered
7.8.5 UCB S.A. Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Glutamate Receptor Ionotropic NMDA 2B Industry Chain Analysis
8.2 Glutamate Receptor Ionotropic NMDA 2B Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
8.3 Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process
8.4 Glutamate Receptor Ionotropic NMDA 2B Sales and Marketing
8.4.1 Glutamate Receptor Ionotropic NMDA 2B Sales Channels
8.4.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
8.5 Glutamate Receptor Ionotropic NMDA 2B Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Glutamate Receptor Ionotropic NMDA 2B CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Glutamate Receptor Ionotropic NMDA 2B Market Trends
Table 3. Glutamate Receptor Ionotropic NMDA 2B Market Drivers
Table 4. Glutamate Receptor Ionotropic NMDA 2B Market Challenges
Table 5. Glutamate Receptor Ionotropic NMDA 2B Market Restraints
Table 6. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Glutamate Receptor Ionotropic NMDA 2B Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Glutamate Receptor Ionotropic NMDA 2B Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Glutamate Receptor Ionotropic NMDA 2B Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Manufacturer, 2017-2022
Table 13. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Glutamate Receptor Ionotropic NMDA 2B Sales Share by Manufacturer, 2017-2022
Table 15. Global Glutamate Receptor Ionotropic NMDA 2B Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Glutamate Receptor Ionotropic NMDA 2B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glutamate Receptor Ionotropic NMDA 2B as of 2021)
Table 18. Top Players of Glutamate Receptor Ionotropic NMDA 2B in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Type
Table 20. Date of International Manufacturers Enter into Glutamate Receptor Ionotropic NMDA 2B Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Glutamate Receptor Ionotropic NMDA 2B Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Glutamate Receptor Ionotropic NMDA 2B Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Glutamate Receptor Ionotropic NMDA 2B Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Glutamate Receptor Ionotropic NMDA 2B Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. BioCrea GmbH Corporation Information
Table 43. BioCrea GmbH Description and Business Overview
Table 44. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product
Table 46. BioCrea GmbH Recent Development
Table 47. Bristol-Myers Squibb Company Corporation Information
Table 48. Bristol-Myers Squibb Company Description and Business Overview
Table 49. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Bristol-Myers Squibb Company Product
Table 51. Bristol-Myers Squibb Company Recent Development
Table 52. Cerecor Inc. Corporation Information
Table 53. Cerecor Inc. Description and Business Overview
Table 54. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Cerecor Inc. Product
Table 56. Cerecor Inc. Recent Development
Table 57. Johnson & Johnson Corporation Information
Table 58. Johnson & Johnson Description and Business Overview
Table 59. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Johnson & Johnson Product
Table 61. Johnson & Johnson Recent Development
Table 62. Luc Therapeutics, Inc. Corporation Information
Table 63. Luc Therapeutics, Inc. Description and Business Overview
Table 64. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Luc Therapeutics, Inc. Product
Table 66. Luc Therapeutics, Inc. Recent Development
Table 67. NeurOp, Inc Corporation Information
Table 68. NeurOp, Inc Description and Business Overview
Table 69. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. NeurOp, Inc Product
Table 71. NeurOp, Inc Recent Development
Table 72. Novartis AG Corporation Information
Table 73. Novartis AG Description and Business Overview
Table 74. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Novartis AG Product
Table 76. Novartis AG Recent Development
Table 77. UCB S.A. Corporation Information
Table 78. UCB S.A. Description and Business Overview
Table 79. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. UCB S.A. Product
Table 81. UCB S.A. Recent Development
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Glutamate Receptor Ionotropic NMDA 2B Customers List
Table 85. Glutamate Receptor Ionotropic NMDA 2B Distributors List
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Glutamate Receptor Ionotropic NMDA 2B Product Picture
Figure 2. Global Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Glutamate Receptor Ionotropic NMDA 2B Market Size 2017-2028 (US$ Million)
Figure 4. Global Glutamate Receptor Ionotropic NMDA 2B Sales 2017-2028 (K Pcs)
Figure 5. United States Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Glutamate Receptor Ionotropic NMDA 2B Market Size 2017-2028 (US$ Million)
Figure 7. United States Glutamate Receptor Ionotropic NMDA 2B Sales 2017-2028 (K Pcs)
Figure 8. United States Glutamate Receptor Ionotropic NMDA 2B Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Glutamate Receptor Ionotropic NMDA 2B Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Glutamate Receptor Ionotropic NMDA 2B Report Years Considered
Figure 11. Product Picture of JNJ-0808
Figure 12. Product Picture of Neu-2000
Figure 13. Product Picture of NP-10679
Figure 14. Product Picture of NP-11948
Figure 15. Product Picture of Radiprodil
Figure 16. Product Picture of Others
Figure 17. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Type in 2022 & 2028
Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Type (2017-2028) & (US$ Million)
Figure 19. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type (2017-2028)
Figure 20. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2028) & (K Pcs)
Figure 21. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type (2017-2028)
Figure 22. Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2017-2028) & (USD/Pcs)
Figure 23. United States Glutamate Receptor Ionotropic NMDA 2B Market Share by Type in 2022 & 2028
Figure 24. United States Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Type (2017-2028) & (US$ Million)
Figure 25. United States Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type (2017-2028)
Figure 26. United States Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2028) & (K Pcs)
Figure 27. United States Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type (2017-2028)
Figure 28. United States Glutamate Receptor Ionotropic NMDA 2B Price by Type (2017-2028) & (USD/Pcs)
Figure 29. Product Picture of Acute Ischemic Stroke
Figure 30. Product Picture of Autism
Figure 31. Product Picture of Brain Ischemia
Figure 32. Product Picture of Burns
Figure 33. Product Picture of Others
Figure 34. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Application in 2022 & 2028
Figure 35. Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application (2017-2028)
Figure 37. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2028) & (K Pcs)
Figure 38. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application (2017-2028)
Figure 39. Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2017-2028) & (USD/Pcs)
Figure 40. United States Glutamate Receptor Ionotropic NMDA 2B Market Share by Application in 2022 & 2028
Figure 41. United States Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Application (2017-2028) & (US$ Million)
Figure 42. United States Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application (2017-2028)
Figure 43. United States Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2028) & (K Pcs)
Figure 44. United States Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application (2017-2028)
Figure 45. United States Glutamate Receptor Ionotropic NMDA 2B Price by Application (2017-2028) & (USD/Pcs)
Figure 46. North America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 47. North America Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. U.S. Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Canada Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 51. Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. Germany Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. France Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.K. Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Italy Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Russia Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 58. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 59. China Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Japan Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. South Korea Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. India Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Australia Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Taiwan Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Indonesia Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Thailand Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Malaysia Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Philippines Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 70. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Mexico Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Brazil Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Argentina Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 75. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 76. Turkey Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. U.A.E Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 79. Glutamate Receptor Ionotropic NMDA 2B Value Chain
Figure 80. Glutamate Receptor Ionotropic NMDA 2B Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed